Clinical Trial Update: Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of AZD5863 in adults with advanced or metastatic solid tumors is currently recruiting, including gastric cancer, gastroesophageal junction can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• AZD5863

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Cancer, Gastro-esophageal Junction Cancer | Phase 1, Phase 2 | Status: RECRUITING